Opioid-Related Disorders, Post Operative Pain
Conditions
Keywords
post operative pain, opioid consumption, erector spinae block, serratus anterior plane block
Brief summary
the aim of the study compare the analgesic effect of erector spinae block and serratus anterior block in breast surgery
Detailed description
Breast reduction surgery is a common cosmetic surgical procedure. Providing effective analgesia has a crucial role in reducing side effects, catalyzing postoperative recovery, and increasing patient satisfaction. Regional anesthesia techniques are generally used for postoperative analgesia to decrease opioid-related side effects. Fascial plane block has gained popularity for breast analgesia. The investigator aimed to consider the effects of ESP block or Serratus Anterior Plane block on postoperative analgesia in breast reduction surgery.
Interventions
PROCEDUREerector spine plane (ESP) block
Bilateral ultrasound guided erector spine plane (ESP) block will be performe preoperatively at T5 level. 20 mL local anesthetics (10 mL 0.5% bupivacaine + 10 mL serum physiologic % l) will be injected deep to the erector spinae muscle.
PROCEDURESerratus Anterior Plane Block
Bilateral ultrasound guided serratus plane block with 20 ml %0,25 bupivacaine at the midaxillary 5. Rib
Sponsors
Sisli Hamidiye Etfal Training and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* American Society of Anesthesiologists (ASA) I-II, * 18-65 years of age, adult, * female patients * undergoing elective breast reduction surgery
Exclusion criteria
* Allergy to amide-type local anesthetics * Infection at the block injection site * Severe obesity (BMI \> 35 kg/m2) * Liver or renal deficiency * Patients with anatomical deformities * Recent use of analgesic drugs * Patient refusal or inability to consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Opioid consumption | 24 hour | Tramadol consumption in Patient Controlled Analgesia device postoperative 24 hours. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain assessed by NRS | 24 hour | Post operative pain will be evaluated with Numeric rating scale (NRS) score of 0-10 (0= no pain and 10= pain) and will be recorded at 0,1,4,12,24. At hours postoperatively. |
| Rate of opioid related side effects | 24 hour | Opioid related side effects such as nause/vomiting, pruritis, bradycardia, hypotension will be evaluated at intervals up to 24 hours. |
| Blooad loss | during surgery | Peroperative and postoperative blood loss and amaoun of eritrosit suspansion |
| Remifentanil consumption | during surgery | Peroperative Remifentanil consumption |
| Length of stay in hospital | 30 days | Length of stay in hospital |
Countries
Turkey (Türkiye)
Contacts
STUDY_CHAIRAYSE SURHAN CINAR
SISLI HAMIDIYE ETFAL RESEARCH AND TRAINING
Outcome results
None listed